China’s NEO Brain Chip Gets Health Insurance, Outpaces Neuralink

China’s Brain Chip Secures Insurance Coverage

China’s NEO brain chip has reportedly outpaced Neuralink, securing commercial approval and eligibility for co-payment under the country’s health insurance program. This minimally invasive brain-computer interface (BCI) is designed to help individuals suffering from paralysis regain mobility.

NEO’s Less Invasive Approach

Unlike Elon Musk’s Neuralink, which involves drilling through the skull and implanting electrodes directly into brain tissue, the NEO system adopts a different strategy. Its less invasive approach prioritizes safety and a clearer path to clinical adoption.

• NEO places eight sensors on the dura mater, the brain’s outer protective membrane, without penetrating the brain itself.
• These sensors communicate with a robotic glove, translating neural signals into motion.
• Neuralink, while demonstrating capabilities like enabling monkeys to play video games, faces regulatory challenges in the U.S.

Global BCI Competition Heats Up

The development highlights a significant global competition in the BCI field. Companies like Paradromics, Synchron (with its Stentrode device), and Blackrock Neurotech are also key players.

These firms often focus on practical, near-term medical benefits and less invasive implantation methods. The broader BCI market is now centered on delivering safe, approved, and accessible products at scale.